Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Immunoprecise Antibodies Ltd IPA

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem... see more

Bullboard (NDAQ:IPA)

View:
Comment by wallpaper2on Aug 05, 2021 7:36pm

RE:Why I'm invested in IPA...

Give it a listen!! Very sobering and certainly aligns with Jennifers early predictions and stance. She/IPA, could be in for a Nobel Prize next December. Not out of the question at all.
Post by mercedesmanon Aug 05, 2021 5:17pm

Why I'm invested in IPA...

https://www.forbes.com/sites/williamhaseltine/2021/08/04/a-warning-about-the-future-of-covid-19-from-the-scientific-advisory-group-for-emergencies-of-the-united-kingdom/?sh=48b416f2e54f This is a ...more  
Post by wallpaper2on Aug 04, 2021 2:20pm

Remember.

19.8 million shares out there in circulation is ridiculously miniscule. Avg, Nasdaq stock has 200 million shares outstanding, some have 500 million o/s.  This could close today at $8.00....open ...more  
Post by wallpaper2on Aug 02, 2021 2:10pm

What's coming down the pipeline?

These have strongly been hinted to be in the pipeline.  Some would occur by summers end. 1- Partnership with Pharma or Foundation 2- Coverage by a US bank or Major Institution 3- NDA ...more  
Post by wallpaper2on Jul 30, 2021 2:09pm

Just read "Over 100 countries with major Delta outbreaks!"

We are all going to be wearing masks again. IPAs cocktail looks so good I had to buy back in. There must be at least one Pharma or Foundation wanting to be the first to own this therapy. Or at least ...more  
Comment by wallpaper2on Jul 29, 2021 8:11pm

RE:Since Last Thursday

CIBC may have purchased that many shares but they appear to have sold just as many or more (algo trading.) I agree with Dart when he says the recent run up looked orchestrated, to allow institutions ...more  
Post by Stocks2Goon Jul 29, 2021 4:21pm

Since Last Thursday

8.7 million shares traded. High was $20.21 / share. CIBC purchased 3.3 million at $13.66. Average price for the 8.7 million traded was $12.61 Last private placement was a bought deal of $21 million at ...more  
Post by dave17on Jul 28, 2021 2:21pm

Check out $Zomd 96% growth very undervalued

https://finance.yahoo.com/news/zoomd-announces-preliminary-2q2021-financial-133000457.html
Comment by dart321on Jul 28, 2021 12:48pm

RE:Contract Research Org. versus Internal Research

To me it looked like this last pump was to get certain institutions that where stuck in this stock, out. Now it will likely drift back to where it should be which is 2 times sales plus cash on hand or ...more  
Post by cleareyeon Jul 28, 2021 8:42am

Contract Research Org. versus Internal Research

I continue to be curious of the business model of being a CRO (contract research organization) vs. the ongoing internal research. I am not sure you can do both. Internal "bamboo curtains" ...more  
Post by cleareyeon Jul 28, 2021 8:38am

News Release and YE Financials Released.

Here's a few highlights: Earned revenues of $17.9 million, a 27% increase which includes a sale through Talem of an internally generated therapeutic antibody for $1.2 million, core CRO ...more  
Comment by Stocks2Goon Jul 26, 2021 12:12pm

RE:RE:Wall Street bets picking up IPA

Even $50 would be great. Such a low float. Only 19 million shares
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities